Showing 251-260 of 767 results for "".
Take 5: New Developments in the Realm of STIs and STDs
https://practicaldermatology.com/columns/take-5/take-5-new-developments-in-the-realm-of-stis-and-stds/21969/New data and recent advancements highlight the importance of education and prevention.Letter to the Editor
https://practicaldermatology.com/columns/letter-to-the-editor/letter-to-the-editor-3/23917/New In My Practice: OTC
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/new-in-my-practice-otc-1/23302/Melanoma Treatment Landscape Evolves
https://practicaldermatology.com/topics/skin-cancer-photoprotection/melanoma-treatment-landscape-evolves/21314/The first agent to target the PD-1 pathway, pembrolizumab may prolong life expectancy in some patients.New Products and Pharmacologic Developments
https://practicaldermatology.com/columns/new-products/new-products-and-pharmacologic-developments/22935/Take 5: Innovations in Aesthetic Treatments
https://practicaldermatology.com/columns/take-5/take-5-innovations-in-aesthetic-treatments/21746/Five new or emerging products may expand skin rejuvenation options.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-37/23755/Evaluation of Cosmetic Training in Dermatology Residency
https://practicaldermatology.com/youngmd-connect/resident-resource-center/evaluation-of-cosmetic-training-in-dermatology-residency/23670/Survey findings highlight the need to expand cosmetic training in US residency programs.Statins and Skin Cancer: The Latest Data
https://practicaldermatology.com/topics/skin-cancer-photoprotection/statins-and-skin-cancer-the-latest-data/20426/A look at another commonly used drug and its potential association with skin cancer risks.Prurigo Nodularis: An Update for Clinicians, Part 2
https://practicaldermatology.com/topics/atopic-dermatitis/prurigo-nodularis-an-update-for-clinicians-part-2/20490/Here's a look at the management of this condition, which is commonly associated with atopic dermatitis.